Westside Investment Management’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.2K | Sell |
8,750
-2,000
| -19% | -$17.4K | 0.01% | 381 |
|
|
2025
Q1 | $85.6K | Buy |
10,750
+1,550
| +17% | +$12.3K | 0.02% | 327 |
|
|
2024
Q4 | $83.6K | Buy |
9,200
+2,800
| +44% | +$25.5K | 0.02% | 331 |
|
|
2024
Q3 | $60.5K | Buy |
6,400
+600
| +10% | +$5.67K | 0.01% | 375 |
|
|
2024
Q2 | $74.3K | Buy |
5,800
+138
| +2% | +$1.77K | 0.02% | 335 |
|
|
2024
Q1 | $85.4K | Buy |
5,662
+1,550
| +38% | +$23.4K | 0.02% | 314 |
|
|
2023
Q4 | $88.6K | Buy |
4,112
+1,300
| +46% | +$28K | 0.02% | 292 |
|
|
2023
Q3 | $52.3K | Buy |
2,812
+100
| +4% | +$1.86K | 0.02% | 334 |
|
|
2023
Q2 | $68.8K | Hold |
2,712
| – | – | 0.02% | 314 |
|
|
2023
Q1 | $67.7K | Buy |
2,712
+930
| +52% | +$23.2K | 0.02% | 317 |
|
|
2022
Q4 | $36.2K | Sell |
1,782
-400
| -18% | -$8.13K | 0.09% | 139 |
|
|
2022
Q3 | $29.2K | Hold |
2,182
| – | – | 0.07% | 159 |
|
|
2022
Q2 | $54.4K | Buy |
2,182
+1,300
| +147% | +$32.4K | 0.12% | 121 |
|
|
2022
Q1 | $29.5K | Buy |
882
+450
| +104% | +$15.1K | 0.06% | 150 |
|
|
2021
Q4 | $12.7K | Buy |
432
+12
| +3% | +$353 | 0.03% | 173 |
|
|
2021
Q3 | $12.7K | Hold |
420
| – | – | 0.03% | 173 |
|
|
2021
Q2 | $16.7K | Buy |
420
+75
| +22% | +$2.98K | 0.04% | 166 |
|
|
2021
Q1 | $18.2K | Buy |
345
+225
| +188% | +$11.9K | 0.05% | 150 |
|
|
2020
Q4 | $23 | Buy |
120
+70
| +140% | +$13 | ﹤0.01% | 413 |
|
|
2020
Q3 | $10 | Buy |
+50
| New | +$10 | ﹤0.01% | 494 |
|
|
2019
Q2 | $26 | Buy |
+400
| New | +$26 | ﹤0.01% | 375 |
|
|
2018
Q4 | $22.3K | Buy |
+450
| New | +$22.3K | 0.01% | 372 |
|
|
2018
Q1 | – | Sell |
-600
| Closed | -$21.6K | – | 837 |
|
|
2017
Q4 | $21.6K | Sell |
600
-300
| -33% | -$10.8K | 0.01% | 399 |
|
|
2017
Q3 | $30.2K | Buy |
900
+500
| +125% | +$16.8K | 0.02% | 331 |
|
|
2017
Q2 | $14K | Hold |
400
| – | – | 0.01% | 452 |
|
|
2017
Q1 | $10.1K | Buy |
+400
| New | +$10.1K | ﹤0.01% | 504 |
|